Center Publications

Any text in center title
Dreffs, A., et al. “All-Trans-Retinaldehyde Contributes To Retinal Vascular Permeability In Ischemia Reperfusion.”. Investigative Ophthalmology & Visual Science, p. 8.
Michigan
Cresci, S., et al. “Genetic Architecture Of Circulating Very-Long-Chain (C24:0 And C22:0) Ceramide Concentrations.”. Journal Of Lipid And Atherosclerosis, pp. 172-183.
WUSTL
Russell, R., et al. “Loss Of The Transcription Factor Mafb Limits Β-Cell Derivation From Human Pscs.”. Nature Communications, p. 2742.
UCSF
Inzucchi, S. E., et al. “Cardiovascular Benefit Of Empagliflozin Across The Spectrum Of Cardiovascular Risk Factor Control In The Empa-Reg Outcome Trial.”. The Journal Of Clinical Endocrinology And Metabolism.
Yale
Syring, K. E., et al. “Potential Positive And Negative Consequences Of Znt8 Inhibition.”. The Journal Of Endocrinology, pp. 189-205.
Vanderbilt
Levitsky, Y., et al. “Mitochondrial Ceramide Effects On The Retinal Pigment Epithelium In Diabetes.”. International Journal Of Molecular Sciences.
Michigan
Boland, M. L., et al. “Resolution Of Nash And Hepatic Fibrosis By The Glp-1R/Gcgr Dual-Agonist Cotadutide Via Modulating Mitochondrial Function And Lipogenesis.”. Nature Metabolism, pp. 413-431.
Vanderbilt
Steinle, J. J. “Review: Role Of Camp Signaling In Diabetic Retinopathy.”. Molecular Vision, pp. 355-358.
Michigan
Griffin, M., et al. “Sodium Glucose Cotransporter 2 Inhibitors As Diuretic Adjuvants In Acute Decompensated Heart Failure: A Case Series.”. Esc Heart Failure, pp. 1966-1971.
Yale
de Brachène, A. C., et al. “Pre-Clinical Evaluation Of Tyk2 Inhibitors For Human Beta Cell Protection In Type 1 Diabetes.”. Diabetes, Obesity & Metabolism.
Indiana
Zhang, L., et al. “Pharmacokinetics (Pk) And Pharmacodynamics (Pd) Of Tti-101, A Stat3 Inhibitor That Blocks Muscle Proteolysis In Rats With Chronic Kidney Disease.”. American Journal Of Physiology. Renal Physiology.
Baylor
 Featured
He, A., et al. “Acetyl-Coa Derived From Hepatic Peroxisomal Β-Oxidation Inhibits Autophagy And Promotes Steatosis Via Mtorc1 Activation.”. Molecular Cell, pp. 30-42.e4.
WUSTL
661 - 672 of 4935